Literature DB >> 8072545

Rapid GDP release from Gs alpha in patients with gain and loss of endocrine function.

T Iiri1, P Herzmark, J M Nakamoto, C van Dop, H R Bourne.   

Abstract

Luteinizing hormone stimulates testicular Leydig cells to produce testosterone by binding to a receptor that activates the G protein Gs and adenylyl cyclase. Testotoxicosis is a form of precocious puberty in which the Leydig cells secrete testosterone in the absence of luteinizing hormone, often due to constitutive activation of the luteinizing hormone receptor and (indirectly) Gs (refs 1-4). Here we study two unrelated boys suffering from a paradoxical combination of testotoxicosis and pseudohypoparathyroidism type Ia (PHP-Ia), a condition marked by resistance to hormones acting through cyclic AMP (parathyroid hormone and thyroid-stimulating hormone) as well as a 50% decrease in erythrocyte Gs activity (the remaining 50% is due to the normal Gs allele). In both patients, a mutation in the gene encoding the Gs alpha-subunit replace alanine at position 366 with serine. We show that this alpha s-A366S mutation constitutively activates adenylyl cyclase in vitro, causing hormone-independent cAMP accumulation when expressed in cultured cells, and accounting for the testotoxicosis phenotype (as cAMP stimulates testosterone secretion). Although alpha s-A366S is quite stable at testis temperature, it is rapidly degraded at 37 degrees C explaining the PHP-Ia phenotype caused by loss of Gs activity. In vitro experiments indicate that accelerated release of GDP causes both the constitutive activity and the thermolability of alpha s-A366S.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8072545     DOI: 10.1038/371164a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  66 in total

Review 1.  Clinical spectrum and pathogenesis of pseudohypoparathyroidism.

Authors:  M A Levine
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

2.  V2 vasopressin receptor (V2R) mutations in partial nephrogenic diabetes insipidus highlight protean agonism of V2R antagonists.

Authors:  Kazuhiro Takahashi; Noriko Makita; Katsunori Manaka; Masataka Hisano; Yuko Akioka; Kenichiro Miura; Noriyuki Takubo; Atsuko Iida; Norishi Ueda; Makiko Hashimoto; Toshiro Fujita; Takashi Igarashi; Takashi Sekine; Taroh Iiri
Journal:  J Biol Chem       Date:  2011-12-05       Impact factor: 5.157

3.  Dynamic Coupling and Allosteric Networks in the α Subunit of Heterotrimeric G Proteins.

Authors:  Xin-Qiu Yao; Rabia U Malik; Nicholas W Griggs; Lars Skjærven; John R Traynor; Sivaraj Sivaramakrishnan; Barry J Grant
Journal:  J Biol Chem       Date:  2015-12-24       Impact factor: 5.157

4.  Structural basis for nucleotide exchange on G alpha i subunits and receptor coupling specificity.

Authors:  Christopher A Johnston; David P Siderovski
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-30       Impact factor: 11.205

5.  Regulation of RhoA signaling by the cAMP-dependent phosphorylation of RhoGDIα.

Authors:  Atsuro Oishi; Noriko Makita; Junichiro Sato; Taroh Iiri
Journal:  J Biol Chem       Date:  2012-09-25       Impact factor: 5.157

6.  A sweet cycle for Arabidopsis G-proteins: Recent discoveries and controversies in plant G-protein signal transduction.

Authors:  Christopher A Johnston; Melinda D Willard; Adam J Kimple; David P Siderovski; Francis S Willard
Journal:  Plant Signal Behav       Date:  2008-12

Review 7.  Mutations of signal-transducing G proteins in human disease.

Authors:  P Schnabel; M Böhm
Journal:  J Mol Med (Berl)       Date:  1995-05       Impact factor: 4.599

Review 8.  Advances in endocrinology.

Authors:  P E Clayton; V Tillmann
Journal:  Arch Dis Child       Date:  1998-03       Impact factor: 3.791

9.  A Gsalpha mutant designed to inhibit receptor signaling through Gs.

Authors:  T Iiri; S M Bell; T J Baranski; T Fujita; H R Bourne
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

Review 10.  Fibrous dysplasia and fibroblast growth factor-23 regulation.

Authors:  Alison M Boyce; Nisan Bhattacharyya; Michael T Collins
Journal:  Curr Osteoporos Rep       Date:  2013-06       Impact factor: 5.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.